Skip to main content

University of Missouri

News

Articles

Clearing the Way for Healthy Arteries

A trio of researchers in Mizzou’s Roy Blunt NextGen Precision Health building have developed a treatment for a leading cause of heart disease in America.

Tom Spencer Leads By Example

Mizzou’s Vice Chancellor for Research has spent decades researching the reproductive system. Now, he’s continuing to lead research into women’s reproductive health with support from a NIH MERIT Award.

Targeted Cancer Cell Therapy May Slow Endometrial Cancer

There may be a way to slow the growth of endometrial cancer through targeted cancer cell therapy, according to new research from the University of Missouri School of Medicine.

Mizzou researcher Dong Xu weighs in on future of artificial intelligence

Artificial intelligence (AI) can write, create videos and power self-driving cars. Someday, University of Missouri researcher Dong Xu predicts, it also will perform surgeries.

Students earn hands-on experience through Summer Research Fellowship Program

Each year, the MU School of Medicine Summer Research Fellowship Program supports original student research under the direct supervision of a faculty member. Students who have completed their first year of medical school are eligible to apply for the program. This summer, 75 medical students participated in the program.

Diabetes Drug Reduces Drug Resistance in Lung Cancer

A medication used to treat diabetic neuropathy may make chemotherapy treatments more effective for patients with lung cancer, according to new findings from NextGen Precision Health researchers.

Scanning for Solutions: 7T MRI Brings New Hope in Epilepsy Treatment

Becky Gooch would feel an aura before one of her absence seizures, a sinking feeling of dread in her stomach that was her sign to sit down in an armchair in her living room and alert her husband, Kevin.

Cracking the Code on Rare Disease Research

Joining the University of Missouri’s NextGen Precision Health team was a logical next step for Kathryn Moss, a neuroscientist intent on understanding Charcot-Marie-Tooth disease.

Harnessing Cancer's Nemesis

Diana Gil Pagés and her team are weaponizing the immune system against cancer. Learn more about their individualized health care approach.

University of Missouri Researcher Awarded $2.2 Million for Non-Radiation Imaging Research

The team is developing a new method for imaging inflammation disorders, such as inflammatory bowel disease (IBD), autoimmune diseases and arthritis.

The Silent Intruder

NextGen Precision Health neuroscientist Smita Saxena explores ALS's insidious path.

An Important Step Forward in the Future of Self-Health Monitoring

The latest innovation from Mizzou engineer Zheng Yan and team is a soft, self-charging material that is battery free.

Improving Access to Care for Rural ALS Patients: "How Can We Make It Easier?"

Jaime Basnett is the the ALS research program manager at Mu Health Care's NextGen Precision Health Institute.

Jianlin "Jack" Cheng Named 2023 AAAS Fellow

The American Association for the Advancement of Science recognized five University of Missouri professors for their distinguished efforts in advancing various fields of science.

Can a Natural Juice Help Your Gut Health?

Research at Mizzou is shedding light on how red cabbage juice might relieve symptoms of digestive disease.

Xiaohua Liu Elected to AIMBE College of Fellows

The NextGen investigator and his College of Engineering colleague Henry Wan have been elected to the 2024 College of Fellows of the American Institute for Medical and Biological Engineering (AIMBE), representing the top 2% of medical and biological engineers in the country.

Revealing the Weakest Link: Leading Neuroscientist Finds Home at NextGen Precision Health

From dissecting neuronal circuits to working on cures for the world’s most prolific neurogenerative diseases, Smita Saxena’s expertise runs the biomedical gamut.

Too Much of a Good Thing: Overconsuming Protein Can Be Bad for Your Health

Researchers have uncovered how consuming dietary protein in excess of the recommended daily allowance triggers signals at the cellular level that result in adverse cardiovascular and metabolic health effects.

NextGen Precision Health Researchers Uncover Potential Treatment for Cardiovascular Complications from Type 2 Diabetes

New research at the Roy Blunt NextGen Precision Health building has discovered a potential treatment for an underlying cause of cardiovascular disease in people with Type 2 diabetes.

Siemens Healthineers interns make strides to improve health care in mid-Missouri

Mizzou students spanning engineering, health sciences and business disciplines worked with Siemens Healthineers to spearhead health care solutions to improve the lives of Missourians.